Does the media refer more to MLAB or QSI?

In the previous week, Mesa Laboratories had 3 more articles in the media than Quantum-Si. MarketBeat recorded 15 mentions for Mesa Laboratories and 12 mentions for Quantum-Si. Mesa Laboratories' average media sentiment score of 0.89 beat Quantum-Si's score of 0.66 indicating that Mesa Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Mesa Laboratories 6 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Quantum-Si 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor CTKB or QSI?

In the previous week, Quantum-Si had 10 more articles in the media than Cytek Biosciences. MarketBeat recorded 12 mentions for Quantum-Si and 2 mentions for Cytek Biosciences. Cytek Biosciences' average media sentiment score of 0.69 beat Quantum-Si's score of 0.66 indicating that Cytek Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cytek Biosciences 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Quantum-Si 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is DNA or QSI more profitable?

Ginkgo Bioworks has a net margin of -259.96% compared to Quantum-Si's net margin of -6,138.26%. Quantum-Si's return on equity of -47.12% beat Ginkgo Bioworks' return on equity. Company Net Margins Return on Equity Return on Assets Ginkgo Bioworks -259.96% -60.27% -26.88% Quantum-Si -6,138.26% -47.12% -43.18%

Does the media prefer DNA or QSI?

In the previous week, Quantum-Si had 9 more articles in the media than Ginkgo Bioworks. MarketBeat recorded 12 mentions for Quantum-Si and 3 mentions for Ginkgo Bioworks. Ginkgo Bioworks' average media sentiment score of 1.22 beat Quantum-Si's score of 0.66 indicating that Ginkgo Bioworks is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ginkgo Bioworks 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Quantum-Si 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings & valuation, QSI or OABI?

OmniAb has higher revenue and earnings than Quantum-Si. OmniAb is trading at a lower price-to-earnings ratio than Quantum-Si, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Quantum-Si $2.44M 69.61 -$101.34M -$0.46 N/A OmniAb $18.67M 33.35 -$64.78M -$0.36 N/A

Is QSI or OABI more profitable?

OmniAb has a net margin of -115.12% compared to Quantum-Si's net margin of -6,138.26%. OmniAb's return on equity of -16.59% beat Quantum-Si's return on equity. Company Net Margins Return on Equity Return on Assets Quantum-Si -6,138.26% -47.12% -43.18% OmniAb -115.12% -16.59% -14.82%

Does the media refer more to QSI or OABI?

In the previous week, OmniAb had 2 more articles in the media than Quantum-Si. MarketBeat recorded 14 mentions for OmniAb and 12 mentions for Quantum-Si. Quantum-Si's average media sentiment score of 0.66 beat OmniAb's score of 0.50 indicating that Quantum-Si is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quantum-Si 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OmniAb 2 Very Positive mention(s) 4 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer QSI or SLP?

In the previous week, Quantum-Si had 7 more articles in the media than Simulations Plus. MarketBeat recorded 12 mentions for Quantum-Si and 5 mentions for Simulations Plus. Simulations Plus' average media sentiment score of 1.58 beat Quantum-Si's score of 0.66 indicating that Simulations Plus is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Quantum-Si 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Simulations Plus 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Quantum-Si (QSI) Competitors

$0.78 +0.01 (+1.29%)

Closing price 08/20/2026 04:00 PM Eastern

Extended Trading

$0.79 +0.01 (+0.77%)

As of 08/20/2026 06:45 PM Eastern

Compare

QSI vs. MLAB, CTKB, DNA, OABI, and SLP

Should you buy Quantum-Si stock or one of its competitors? Quantum-Si's main competitors and comparable companies include Mesa Laboratories (MLAB), Cytek Biosciences (CTKB), Ginkgo Bioworks (DNA), OmniAb (OABI), and Simulations Plus (SLP). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "life sciences tools & services" industry.

How does Quantum-Si compare to Mesa Laboratories?

Mesa Laboratories (NASDAQ:MLAB) and Quantum-Si (NASDAQ:QSI) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, media sentiment, valuation, risk and institutional ownership.

Mesa Laboratories presently has a consensus target price of $110.00, suggesting a potential downside of 7.68%. Quantum-Si has a consensus target price of $1.00, suggesting a potential upside of 28.21%. Given Quantum-Si's higher possible upside, analysts clearly believe Quantum-Si is more favorable than Mesa Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Mesa Laboratories	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Quantum-Si	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Mesa Laboratories has a net margin of 1.92% compared to Quantum-Si's net margin of -6,138.26%. Mesa Laboratories' return on equity of 22.72% beat Quantum-Si's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Mesa Laboratories	1.92%	22.72%	9.82%
Quantum-Si	-6,138.26%	-47.12%	-43.18%

90.6% of Mesa Laboratories shares are held by institutional investors. Comparatively, 39.9% of Quantum-Si shares are held by institutional investors. 2.8% of Mesa Laboratories shares are held by insiders. Comparatively, 22.0% of Quantum-Si shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Mesa Laboratories has higher revenue and earnings than Quantum-Si. Quantum-Si is trading at a lower price-to-earnings ratio than Mesa Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Mesa Laboratories	$249.13M	2.68	$6.71M	$0.84	141.85
Quantum-Si	$2.44M	69.61	-$101.34M	-$0.46	N/A

In the previous week, Mesa Laboratories had 3 more articles in the media than Quantum-Si. MarketBeat recorded 15 mentions for Mesa Laboratories and 12 mentions for Quantum-Si. Mesa Laboratories' average media sentiment score of 0.89 beat Quantum-Si's score of 0.66 indicating that Mesa Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Mesa Laboratories	6 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Quantum-Si	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Mesa Laboratories has a beta of 0.92, indicating that its stock price is 8% less volatile than the broader market. Comparatively, Quantum-Si has a beta of 3.24, indicating that its stock price is 224% more volatile than the broader market.

Summary

Mesa Laboratories beats Quantum-Si on 10 of the 15 factors compared between the two stocks.

How does Quantum-Si compare to Cytek Biosciences?

Cytek Biosciences (NASDAQ:CTKB) and Quantum-Si (NASDAQ:QSI) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, earnings, risk, analyst recommendations, institutional ownership, dividends, media sentiment and valuation.

In the previous week, Quantum-Si had 10 more articles in the media than Cytek Biosciences. MarketBeat recorded 12 mentions for Quantum-Si and 2 mentions for Cytek Biosciences. Cytek Biosciences' average media sentiment score of 0.69 beat Quantum-Si's score of 0.66 indicating that Cytek Biosciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cytek Biosciences	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Quantum-Si	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Cytek Biosciences has higher revenue and earnings than Quantum-Si. Cytek Biosciences is trading at a lower price-to-earnings ratio than Quantum-Si, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cytek Biosciences	$201.49M	3.01	-$66.54M	-$0.62	N/A
Quantum-Si	$2.44M	69.61	-$101.34M	-$0.46	N/A

Cytek Biosciences presently has a consensus target price of $5.56, indicating a potential upside of 19.37%. Quantum-Si has a consensus target price of $1.00, indicating a potential upside of 28.21%. Given Quantum-Si's higher possible upside, analysts clearly believe Quantum-Si is more favorable than Cytek Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cytek Biosciences	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
Quantum-Si	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

69.5% of Cytek Biosciences shares are held by institutional investors. Comparatively, 39.9% of Quantum-Si shares are held by institutional investors. 10.4% of Cytek Biosciences shares are held by insiders. Comparatively, 22.0% of Quantum-Si shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Cytek Biosciences has a beta of 1.17, indicating that its stock price is 17% more volatile than the broader market. Comparatively, Quantum-Si has a beta of 3.24, indicating that its stock price is 224% more volatile than the broader market.

Cytek Biosciences has a net margin of -38.98% compared to Quantum-Si's net margin of -6,138.26%. Cytek Biosciences' return on equity of -12.40% beat Quantum-Si's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cytek Biosciences	-38.98%	-12.40%	-9.17%
Quantum-Si	-6,138.26%	-47.12%	-43.18%

Summary

Cytek Biosciences beats Quantum-Si on 9 of the 16 factors compared between the two stocks.

How does Quantum-Si compare to Ginkgo Bioworks?

Ginkgo Bioworks (NYSE:DNA) and Quantum-Si (NASDAQ:QSI) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, media sentiment, analyst recommendations, risk, dividends and valuation.

Ginkgo Bioworks presently has a consensus target price of $7.00, suggesting a potential upside of 0.14%. Quantum-Si has a consensus target price of $1.00, suggesting a potential upside of 28.21%. Given Quantum-Si's stronger consensus rating and higher probable upside, analysts plainly believe Quantum-Si is more favorable than Ginkgo Bioworks.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ginkgo Bioworks	2 Sell rating(s)	2 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Quantum-Si	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Ginkgo Bioworks has a beta of 1.78, meaning that its stock price is 78% more volatile than the broader market. Comparatively, Quantum-Si has a beta of 3.24, meaning that its stock price is 224% more volatile than the broader market.

Ginkgo Bioworks has a net margin of -259.96% compared to Quantum-Si's net margin of -6,138.26%. Quantum-Si's return on equity of -47.12% beat Ginkgo Bioworks' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ginkgo Bioworks	-259.96%	-60.27%	-26.88%
Quantum-Si	-6,138.26%	-47.12%	-43.18%

Quantum-Si has lower revenue, but higher earnings than Ginkgo Bioworks. Quantum-Si is trading at a lower price-to-earnings ratio than Ginkgo Bioworks, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ginkgo Bioworks	$170.15M	2.77	-$312.76M	-$5.01	N/A
Quantum-Si	$2.44M	69.61	-$101.34M	-$0.46	N/A

In the previous week, Quantum-Si had 9 more articles in the media than Ginkgo Bioworks. MarketBeat recorded 12 mentions for Quantum-Si and 3 mentions for Ginkgo Bioworks. Ginkgo Bioworks' average media sentiment score of 1.22 beat Quantum-Si's score of 0.66 indicating that Ginkgo Bioworks is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ginkgo Bioworks	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Quantum-Si	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

78.6% of Ginkgo Bioworks shares are held by institutional investors. Comparatively, 39.9% of Quantum-Si shares are held by institutional investors. 12.7% of Ginkgo Bioworks shares are held by company insiders. Comparatively, 22.0% of Quantum-Si shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Quantum-Si beats Ginkgo Bioworks on 10 of the 16 factors compared between the two stocks.

How does Quantum-Si compare to OmniAb?

Quantum-Si (NASDAQ:QSI) and OmniAb (NASDAQ:OABI) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, media sentiment, dividends, profitability, valuation and risk.

OmniAb has a net margin of -115.12% compared to Quantum-Si's net margin of -6,138.26%. OmniAb's return on equity of -16.59% beat Quantum-Si's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quantum-Si	-6,138.26%	-47.12%	-43.18%
OmniAb	-115.12%	-16.59%	-14.82%

Quantum-Si currently has a consensus target price of $1.00, indicating a potential upside of 28.21%. OmniAb has a consensus target price of $11.00, indicating a potential upside of 155.81%. Given OmniAb's stronger consensus rating and higher possible upside, analysts plainly believe OmniAb is more favorable than Quantum-Si.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quantum-Si	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
OmniAb	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

In the previous week, OmniAb had 2 more articles in the media than Quantum-Si. MarketBeat recorded 14 mentions for OmniAb and 12 mentions for Quantum-Si. Quantum-Si's average media sentiment score of 0.66 beat OmniAb's score of 0.50 indicating that Quantum-Si is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quantum-Si	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OmniAb	2 Very Positive mention(s)	4 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

39.9% of Quantum-Si shares are held by institutional investors. Comparatively, 72.1% of OmniAb shares are held by institutional investors. 22.0% of Quantum-Si shares are held by insiders. Comparatively, 9.8% of OmniAb shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Quantum-Si has a beta of 3.24, suggesting that its stock price is 224% more volatile than the broader market. Comparatively, OmniAb has a beta of 0.45, suggesting that its stock price is 55% less volatile than the broader market.

OmniAb has higher revenue and earnings than Quantum-Si. OmniAb is trading at a lower price-to-earnings ratio than Quantum-Si, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quantum-Si	$2.44M	69.61	-$101.34M	-$0.46	N/A
OmniAb	$18.67M	33.35	-$64.78M	-$0.36	N/A

Summary

OmniAb beats Quantum-Si on 11 of the 16 factors compared between the two stocks.

How does Quantum-Si compare to Simulations Plus?

Quantum-Si (NASDAQ:QSI) and Simulations Plus (NASDAQ:SLP) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk and profitability.

Simulations Plus has a net margin of 9.88% compared to Quantum-Si's net margin of -6,138.26%. Simulations Plus' return on equity of 13.50% beat Quantum-Si's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Quantum-Si	-6,138.26%	-47.12%	-43.18%
Simulations Plus	9.88%	13.50%	12.45%

In the previous week, Quantum-Si had 7 more articles in the media than Simulations Plus. MarketBeat recorded 12 mentions for Quantum-Si and 5 mentions for Simulations Plus. Simulations Plus' average media sentiment score of 1.58 beat Quantum-Si's score of 0.66 indicating that Simulations Plus is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Quantum-Si	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Simulations Plus	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

39.9% of Quantum-Si shares are owned by institutional investors. Comparatively, 78.1% of Simulations Plus shares are owned by institutional investors. 22.0% of Quantum-Si shares are owned by company insiders. Comparatively, 19.1% of Simulations Plus shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Quantum-Si currently has a consensus price target of $1.00, indicating a potential upside of 28.21%. Simulations Plus has a consensus price target of $17.25, indicating a potential downside of 6.15%. Given Quantum-Si's stronger consensus rating and higher possible upside, research analysts plainly believe Quantum-Si is more favorable than Simulations Plus.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quantum-Si	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Simulations Plus	1 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.88

Quantum-Si has a beta of 3.24, suggesting that its share price is 224% more volatile than the broader market. Comparatively, Simulations Plus has a beta of 1.32, suggesting that its share price is 32% more volatile than the broader market.

Simulations Plus has higher revenue and earnings than Quantum-Si. Quantum-Si is trading at a lower price-to-earnings ratio than Simulations Plus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quantum-Si	$2.44M	69.61	-$101.34M	-$0.46	N/A
Simulations Plus	$79.18M	4.70	-$64.72M	$0.40	45.95

Summary

Simulations Plus beats Quantum-Si on 9 of the 16 factors compared between the two stocks.

Get Quantum-Si News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding QSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

QSI vs. The Competition

Export

Metric	Quantum-Si	Life Sciences Tools & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$167.70M	$9.97B	$7.36B	$12.86B
Dividend Yield	N/A	1.46%	2.54%	10.68%
P/E Ratio	-1.70	59.43	268.94	24.05
Price / Sales	69.61	111.98	629.33	95.10
Price / Cash	N/A	26.52	78.13	53.57
Price / Book	0.94	37.23	13.07	6.15
Net Income	-$101.34M	$56.67B	$3.46B	$347.39M
7 Day Performance	5.43%	4.02%	1.10%	-0.86%
1 Month Performance	-6.70%	8.13%	3.99%	1.13%
1 Year Performance	-29.73%	26.73%	26.52%	19.65%

Quantum-Si Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
QSI Quantum-Si	2.7167 of 5 stars	$0.78 +1.3%	$1.00 +28.2%	-22.0%	$167.70M	$2.44M	N/A	150	Analyst Revision
MLAB Mesa Laboratories	1.4684 of 5 stars	$101.62 -1.0%	$94.00 -7.5%	+73.0%	$574.42M	$249.13M	84.68	680
CTKB Cytek Biosciences	2.2688 of 5 stars	$4.66 +11.0%	$5.56 +19.4%	+16.5%	$545.93M	$201.49M	N/A	500	Gap Up
DNA Ginkgo Bioworks	1.2234 of 5 stars	$7.66 -3.9%	$7.00 -8.6%	-39.7%	$520.64M	$170.15M	N/A	640	Gap Down
OABI OmniAb	2.2199 of 5 stars	$3.39 +10.1%	N/A	+135.0%	$445.93M	$18.67M	N/A	7	High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:QSI) was last updated on 8/21/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Quantum-Si (QSI) Competitors

QSI vs. MLAB, CTKB, DNA, OABI, and SLP

How does Quantum-Si compare to Mesa Laboratories?

Summary

How does Quantum-Si compare to Cytek Biosciences?

Summary

How does Quantum-Si compare to Ginkgo Bioworks?

Summary

How does Quantum-Si compare to OmniAb?

Summary

How does Quantum-Si compare to Simulations Plus?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QSI vs. The Competition

Quantum-Si Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Quantum-Si (QSI) Competitors

QSI vs. MLAB, CTKB, DNA, OABI, and SLP

How does Quantum-Si compare to Mesa Laboratories?

Do analysts prefer MLAB or QSI?

Is MLAB or QSI more profitable?

Do institutionals & insiders hold more shares of MLAB or QSI?

Which has preferable earnings and valuation, MLAB or QSI?

Does the media refer more to MLAB or QSI?

Which has more risk and volatility, MLAB or QSI?

Summary

How does Quantum-Si compare to Cytek Biosciences?

Does the media favor CTKB or QSI?

Which has preferable valuation and earnings, CTKB or QSI?

Do analysts rate CTKB or QSI?

Do insiders and institutionals believe in CTKB or QSI?

Which has more risk and volatility, CTKB or QSI?

Is CTKB or QSI more profitable?

Summary

How does Quantum-Si compare to Ginkgo Bioworks?

Do analysts recommend DNA or QSI?

Which has more volatility & risk, DNA or QSI?

Is DNA or QSI more profitable?

Which has preferable earnings and valuation, DNA or QSI?

Does the media prefer DNA or QSI?

Do institutionals and insiders have more ownership in DNA or QSI?

Summary

How does Quantum-Si compare to OmniAb?

Is QSI or OABI more profitable?

Do analysts recommend QSI or OABI?

Does the media refer more to QSI or OABI?

Do insiders & institutionals believe in QSI or OABI?

Which has more risk & volatility, QSI or OABI?

Which has stronger earnings & valuation, QSI or OABI?

Summary

How does Quantum-Si compare to Simulations Plus?

Is QSI or SLP more profitable?

Does the media prefer QSI or SLP?

Do institutionals & insiders believe in QSI or SLP?

Do analysts recommend QSI or SLP?

Which has more risk and volatility, QSI or SLP?

Which has higher earnings and valuation, QSI or SLP?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

QSI vs. The Competition

Quantum-Si Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools